rs121918290
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_004183.4(BEST1):c.715G>A(p.Val239Met) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V239A) has been classified as Uncertain significance.
Frequency
Consequence
NM_004183.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant vitreoretinochoroidopathyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- inherited retinal dystrophyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosaInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
- vitelliform macular dystrophy 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- autosomal recessive bestrophinopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosa 50Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- adult-onset foveomacular vitelliform dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- MRCS syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- nanophthalmiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BEST1 | NM_004183.4 | c.715G>A | p.Val239Met | missense_variant, splice_region_variant | Exon 7 of 11 | ENST00000378043.9 | NP_004174.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BEST1 | ENST00000378043.9 | c.715G>A | p.Val239Met | missense_variant, splice_region_variant | Exon 7 of 11 | 1 | NM_004183.4 | ENSP00000367282.4 |
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 0
ClinVar
Submissions by phenotype
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2 Pathogenic:1
- -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; An in vitro splicing assay suggested that V239M causes skipping of exons 6 and 7 and results in the production of bestrophin-1 isoforms containing in-frame deletions, possibly due to the disruption of an exonic splice enhancer. However, in vivo studies have not been performed to validate these findings (Yardley et al., 2004); This variant is associated with the following publications: (PMID: 15452077, 18611979, 24560797, 17065513, 26771239, 21473666, 30222024, 22454052, 24328569, 20362068, 19375515, 18391176, 30945270, 34746433, 27653836) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at